SBC Medical Group announces ‘SBC Wellness 2.0’ strategy

SBC Medical Group (SBC) Holdings announced “SBC Wellness 2.0,” a new wellness and longevity platform that combines aesthetic healthcare, preventative care, and data-driven health management. The initiative positions SBC Medical to participate in the fast-growing longevity market, which is projected to reach approximately $800B in 2025 and expand to approximately $2T by 2035, with a compound annual growth rate exceeding 10% from 2026 to 2035. This strategy represents a natural extension of SBC Medical’s core business in Japan’s approximately $4B aesthetic healthcare market. While Japan’s domestic longevity market has already reached an estimated $34B, it remains in its early stages with no clear market leader, providing a significant opportunity for the Company to capture first-mover advantages. SBC Medical intends to use its existing clinic network and customer base in Japan to build recurring revenue streams and a differentiated, data-rich platform. “Through aesthetic healthcare, we have helped many people build confidence in their appearance,” said Yoshiyuki Aikawa, CEO. “What we have come to realize is that those who seek a youthful look are equally attuned to the signs of internal physical decline. SBC Wellness 2.0 was born from this insight. We are confident that only SBC Medical can deliver a standard of care that allows individuals to pursue ‘their best-ever self’ – across both appearance and physical function. We will first become the game changer in Japan’s domestic longevity market and then set our sights on the world.”